Edward Dumoulin at Goldman Ismail Tomaselli Brennan & Baum LLP has a growing reputation for his work in nationwide product liability and antitrust matters. Dumoulin represents chemical, pharma and vaccine manufacturers in disputes, including Merck’s Gardasil litigation and matters for Bayer involving pharma products, and is noted for his thorough handling of briefing strategy, motions practice and appellate issues.
Legal 500 Editorial commentary
Phone
312-881-5945
Email
Profile

Accolades

Chicago Elite

Profile

Position

Partner

Career

Ed represents clients in high-stakes civil cases across a variety of practice areas including product liability, antitrust, and complex commercial litigation. His work has led to dozens of victories and recognition by Law360 as one of four Rising Stars chosen nationwide in product liability practice. Ed has briefed and argued motions that have resulted in litigation-wide impact in MDLs, and that have led to dismissals based on issues of federal preemption or jurisdiction in numerous individual suits. Ed’s briefing has additionally led courts to grant summary judgment, exclude adversaries’ key experts, and deny requests to create MDLs. He has also managed large-scale litigation, developed case strategy, deposed key witnesses, and served on trial teams in cases with billions of dollars in dispute.

Beyond litigating in trial courts nationwide, Ed maintains an active appellate practice. He has argued in the First, Fourth, Seventh, and Ninth Circuits and briefed appeals elsewhere, including the Second, Third, and Eleventh Circuits. Ed has also practiced before the United States Supreme Court, including in a recent case where he drafted a certiorari petition leading the Court to vacate a ruling of the Ninth Circuit.

Ed obtained his undergraduate and law degrees from Harvard, where he won the Boylston Prize for Elocution. He also earned a master’s degree from the University of Cambridge in the UK. He joined Goldman Ismail after completing federal clerkships in a district court and the Second Circuit and practicing with another leading national law firm.

Content supplied by Goldman Ismail Tomaselli Brennan & Baum LLP

Key clients

  • Merck & Co. Inc.; Merck Sharp & Dohme LLC
  • Bayer HealthCare Pharmaceuticals Inc.; Bayer HealthCare LLC; Bayer Corp.

Work highlights

Serving as lead national counsel in all U.S.-based products liability litigation relating to Merck’s Gardasil vaccine, which protects against HPV infection and cervical other types of cancer caused by HPV infection.